Freedom of information
CDER's Division of Freedom of Information, currently under Office of Training and Communications Director Nancy Smith, will be renamed the Division of Information Disclosure Policy. The division will be moved under CDER Associate Director for Policy Jane Axelrad
You may also be interested in...
Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, will serve as the center's acting director for the next several months
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials